FluidAI is revolutionizing the healthcare system by providing data-driven patient recovery solutions using AI. FluidAI has developed Stream™ Platform, a postoperative monitoring system to detect early signs of complications such as anastomotic (gastrointestinal) leaks, mitigating the risks associated with delayed detection. Stream™ Platform comprises a proprietary hardware device known as Origin™, equipped with nanosensors for the compositional analysis of drainage fluid post-surgery, and the Stream™ app integrated with the Electronic Health Record. The app charts patient recovery visualizes the patient’s data, and displays FluidAI's risk scores. FluidAI’s technology allows a paradigm shift in the standard of care from delayed and reactive to predictive and proactive. FluidAI's recent achievements include a commercial Limited Market Release, strategic partnerships with companies like Medtronic, and healthcare institutions such as Cleveland Clinic and Mayo Clinic, distribution contracts with key players, and a successful $15 million USD Series A in 2023.